Huadong Medicine Valuation
| 000963 Stock | 35.95 0.24 0.66% |
At this time, the firm appears to be undervalued. Huadong Medicine retains a regular Real Value of USD40.03 per share. The prevalent price of the firm is USD35.95. Our model calculates the value of Huadong Medicine from evaluating the firm fundamentals such as return on asset of 0.0671, and Return On Equity of 0.15 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 2.8612 | Enterprise Value 60.7 B | Enterprise Value Ebitda 15.0648 | Price Sales 1.5121 | Trailing PE 19.6448 |
Undervalued
Today
Please note that Huadong Medicine's price fluctuation is very steady at this time. Calculation of the real value of Huadong Medicine is based on 3 months time horizon. Increasing Huadong Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Huadong Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Huadong Stock. However, Huadong Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.95 | Real 40.03 | Hype 35.04 |
The real value of Huadong Stock, also known as its intrinsic value, is the underlying worth of Huadong Medicine Company, which is reflected in its stock price. It is based on Huadong Medicine's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Huadong Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Huadong Medicine Co helps investors to forecast how Huadong stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Huadong Medicine more accurately as focusing exclusively on Huadong Medicine's fundamentals will not take into account other important factors: Huadong Medicine Cash |
|
Huadong Medicine Total Value Analysis
Huadong Medicine Co is presently forecasted to have takeover price of 60.7 B with market capitalization of 63.07 B, debt of 822.38 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Huadong Medicine fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
60.7 B | 63.07 B | 822.38 M |
Huadong Medicine Investor Information
About 58.0% of the company shares are owned by insiders or employees . The book value of Huadong Medicine was presently reported as 12.64. The company last dividend was issued on the 20th of September 2024. Huadong Medicine had 1.2:1 split on the 21st of June 2019. Based on the measurements of operating efficiency obtained from Huadong Medicine's historical financial statements, Huadong Medicine Co is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 4.1 B | 3.9 B |
|
| |||||
| Operating Income | 4 B | 3.8 B |
|
|
Huadong Medicine Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Huadong Medicine has an asset utilization ratio of 121.23 percent. This suggests that the Company is making USD1.21 for each dollar of assets. An increasing asset utilization means that Huadong Medicine Co is more efficient with each dollar of assets it utilizes for everyday operations.Huadong Medicine Ownership Allocation
Huadong Medicine Co has a total of 1.75 Billion outstanding shares. Huadong Medicine secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Huadong Medicine Profitability Analysis
The company reported the revenue of 40.62 B. Net Income was 2.84 B with profit before overhead, payroll, taxes, and interest of 12.03 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Huadong Medicine's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Huadong Medicine and how it compares across the competition.
About Huadong Medicine Valuation
The stock valuation mechanism determines Huadong Medicine's current worth on a weekly basis. Our valuation model uses a comparative analysis of Huadong Medicine. We calculate exposure to Huadong Medicine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Huadong Medicine's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 13.2 B | 10.5 B |
Complementary Tools for Huadong Stock analysis
When running Huadong Medicine's price analysis, check to measure Huadong Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Huadong Medicine is operating at the current time. Most of Huadong Medicine's value examination focuses on studying past and present price action to predict the probability of Huadong Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Huadong Medicine's price. Additionally, you may evaluate how the addition of Huadong Medicine to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |